Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023
Revenues:
Revenue		$ 0	$ 5,442
Operating expenses:
Research and development		5,387	9,023
General and administrative		8,145	12,142
Total operating expenses		13,532	21,165
Loss from operations		(13,532)	(15,723)
Other (expense) income :
Interest income		111	325
Interest expense		138	(337)
Change in fair value of rights from Private Placement		(3,832)	1,582
Change in fair value measurement of notes payable		(9)	(22)
Other (expense) income, net		(13)	99
Total other (expense) income, net		(3,605)	1,647
Net loss		(17,137)	(14,076)
Net (loss) income attributable to noncontrolling interest		(5)	23
Net loss attributable to Kineta, Inc.		$ (17,132)	$ (14,099)
Net loss per share, basic		$ (1.42)	$ (1.28)
Net loss per share, diluted		$ (1.42)	$ (1.28)
Weighted-average shares outstanding, basic	[1]	12,100	11,054
Weighted-average shares outstanding, diluted	[1]	12,100	11,054
license and collaboration
Revenues:
Revenue		$ 0	$ 5,000
Collaboration revenue [Member]
Revenues:
Revenue		$ 0	$ 442

[1] Included in the denominator for the years ended December 31, 2024 and 2023, were 286,000 and 628,000 weighted-average shares of common stock warrants, respectively, with exercise prices of $0.001 and $0.14 issued for nominal consideration.